CD38 and neoplasm: Baseline CD38 expression level on NKTCL tumor tissue also had no direct association with response, suggesting that a complex combination of NK-cytotoxic activity and tumor microenvironment modulation functions of daratumumab needs to be considered to dissect the contribution of antitumor effects.